feed,title,long_url,short_url
Benzinga,Janssen Secures Conditional EU Marketing Authorization For Rybrevant in Lung Cancer Setting,https://benzinga.com/general/biotech/21/12/24570795/janssen-secures-conditional-eu-marketing-authorization-for-rybrevant-in-lung-cancer-setting,https://j.mp/3s9BH7k
Benzinga,Worthington Industries: Debt Overview,https://benzinga.com/news/21/12/24570883/worthington-industries-debt-overview,https://j.mp/3oNt0h9
Benzinga,Tsakos Energy Navigation's Debt Overview,https://benzinga.com/news/21/12/24570946/tsakos-energy-navigations-debt-overview,https://j.mp/3dKdLiv
Benzinga,A Look Into Steelcase's Debt,https://benzinga.com/news/21/12/24570904/a-look-into-steelcases-debt,https://j.mp/33roaOo
Benzinga,Jabil's Debt Overview,https://benzinga.com/news/21/12/24570917/jabils-debt-overview,https://j.mp/31MqgrN
Benzinga,A Look Into Quanex Building Products Debt,https://benzinga.com/news/21/12/24570920/a-look-into-quanex-building-products-debt,https://j.mp/3GGdJok
Benzinga,JNJ's Janssen Posts Two Years Survival Data On BCMA Cell Therapy In Multiple Myeloma,https://benzinga.com/general/biotech/21/12/24570279/jnjs-janssen-posts-two-years-survival-data-on-bcma-cell-therapy-in-multiple-myeloma,https://j.mp/3pRzcnJ
